Skip to main content
. 2022 May 31;95(9):1871–1879. doi: 10.1007/s00420-022-01884-2

Table 2.

Prevalence, incidence, remitted, and persistent proportions of airway symptoms in the study population (N = 5017)

Measure Wheezea Long-standing cougha Productive cougha
N % N % N %
Baseline prevalence 936/5017 18.7 1086/5017 21.7 1000/5017 19.9
Cumulative incidence proportionb 341/(5017–936) 8.4 350/(5017–1086) 8.9 417/(5017–1000) 10.4
Annual incidence proportion 341/(5017–936)/6 1.4 350/(5017–1086)/6 1.5 417/(5017–1000)/6 1.7
Remitted proportionc 442/936 47.2 658/1086 60.6 468/1000 46.8
Annual remitted proportion 442/936/6 7.9 658/1086/6 10.1 468/1000/6 7.8
Persistent proportiond (936–442)/936 52.8 (1086–658)/1086 39.4 (1000−468)/1000 53.2

aThe figures are affected by item non-response, and absolute percentages are presented

bThe number of incident cases divided by subjects at risk (total sample minus subjects with symptoms at baseline)

cThe number of remitted cases divided by the number of subjects with symptoms at baseline

dThe number of persistent cases (subjects with symptoms at baseline minus number of remitted cases) divided by the number of subjects with symptoms at baseline